High-Resolution Profiling of Lung Adenocarcinoma Identifies Expression Subtypes with Specific Biomarkers and Clinically Relevant Vulnerabilities.
Whijae RohYifat GeffenHongui ChaMendy MillerShankara K AnandJaegil KimDavid I HeimanJustin F GainorPeter W LairdAndrew D CherniakChan-Young OckSe-Hoon LeeGad A Getznull nullPublished in: Cancer research (2022)
Integrative analysis of multiomic and drug dependency data uncovers robust lung adenocarcinoma expression subtypes with unique therapeutic vulnerabilities and subtype-specific biomarkers of response.